We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$926M
AUM Growth
+$30.2M
Cap. Flow
-$624K
Cap. Flow %
-0.07%
Top 10 Hldgs %
33.19%
Holding
282
New
18
Increased
64
Reduced
120
Closed
10

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.11M
2
WKC icon
World Kinect Corp
WKC
+$5.07M
3
WELL icon
Welltower
WELL
+$3.73M
4
BKE icon
Buckle
BKE
+$3.44M
5
HOUS
Anywhere Real Estate
HOUS
+$3.18M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$12.3M
2
INTC icon
Intel
INTC
+$5.89M
3
DD
Du Pont De Nemours E I
DD
+$3.9M
4
MTB icon
M&T Bank
MTB
+$2.69M
5
NSR
Neustar Inc
NSR
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Industrials 16.32%
3 Healthcare 14.58%
4 Consumer Discretionary 13.74%
5 Financials 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRGA
251
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$154K 0.02%
1,283
– –
ALOT icon
252
AstroNova
ALOT
$224M
$153K 0.02%
10,004
– –
TVIA
253
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$153K 0.02%
211,600
-12,500
-6% -$11.6K
AAME icon
254
Atlantic American Corp
AAME
$31.6M
$152K 0.02%
38,050
– –
TURN
255
DELISTED
180 Degree Capital
TURN
$143K 0.02%
32,833
– –
FEIM icon
256
Frequency Electronics
FEIM
$697M
$140K 0.02%
12,691
+1,000
+9% +$11K
JQC icon
257
Nuveen Credit Strategies Income Fund
JQC
$702M
$133K 0.01%
15,300
– –
FCO
258
DELISTED
abrdn Global Income Fund
FCO
$132K 0.01%
+15,700
New +$131K
OXSQ icon
259
Oxford Square Capital
OXSQ
$148M
$129K 0.01%
17,500
– –
MSD
260
Morgan Stanley Emerging Markets Debt Fund
MSD
$147M
$116K 0.01%
12,450
– –
EHI
261
Western Asset Global High Income Fund
EHI
$175M
$112K 0.01%
11,102
– –
JPC icon
262
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$108K 0.01%
11,000
– –
MIND icon
263
MIND Technology
MIND
$48M
$104K 0.01%
2,120
-40
-2% -$1.86K
PED icon
264
PEDEVCO
PED
$153M
$90K 0.01%
+4,885
New +$103K
SNT
265
Senstar Technologies
SNT
$41.3M
$85K 0.01%
11,335
– –
ARTW icon
266
Arts-Way Manufacturing Co
ARTW
$12.4M
$62K 0.01%
17,775
– –
ARLZ
267
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$49K 0.01%
22,987
+1,500
+7% +$5.64K
EQS icon
268
Equus Total Return
EQS
$17M
$44K ﹤0.01%
17,735
– –
MUX icon
269
McEwen Inc
MUX
$1.04B
$30K ﹤0.01%
1,000
– –
PDLI
270
DELISTED
PDL BioPharma, Inc.
PDLI
$26K ﹤0.01%
+11,500
New +$25.4K
ALIM
271
DELISTED
Alimera Sciences
ALIM
$14K ﹤0.01%
+667
New +$12.8K
CVM icon
272
CEL-SCI Corp
CVM
$20.6M
$1K ﹤0.01%
13
– –
AA icon
273
Alcoa
AA
$11.6B
– –
-10,423
Closed -$293K
CHTR icon
274
Charter Communications
CHTR
$15.7B
– –
-2,077
Closed -$598K
ES icon
275
Eversource Energy
ES
$28.1B
– –
-4,400
Closed -$243K
8 9 10
11
12

Similar funds

SVWAG
Sound View Wealth Advisors Group Savannah, Georgia $1.47B AUM 18.47% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
CWM
Cahaba Wealth Management Atlanta, Georgia $1.47B AUM 13.36% 1-Year Est. Return
AAIM
American Assets Investment Management San Diego, California $1.47B AUM 43% 1-Year Est. Return
SWA
SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return
VCP
Verus Capital Partners Scottsdale, Arizona $1.46B AUM 27.29% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
ACM
Adelante Capital Management Alameda, California $1.46B AUM 8.98% 1-Year Est. Return

Shufro Rose & Co's Q1 2017 Portfolio in Review

As of Q1 2017, Shufro Rose & Co held 282 positions worth $926M, up 3.4% from $896M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Shufro Rose & Co's Q1 2017 filing shows 18 new, 64 increased, 120 reduced and 10 closed positions. Its largest new stake was Welltower: 55,350 shares worth $3.92M. The largest sale was UnitedHealth, an estimated $12.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Shufro Rose & Co's largest Q1 2017 buy was Welltower: 55,350 shares worth $3.92M.
  • Shufro Rose & Co added most to Bristol-Myers Squibb in Q1 2017, an estimated $6.11M increase.
  • Shufro Rose & Co's biggest Q1 2017 reduction was UnitedHealth, cutting an estimated $12.3M.
  • Shufro Rose & Co fully exited Time Warner Inc in Q1 2017, selling an estimated $1.93M.
  • Shufro Rose & Co's ten largest holdings make up 33% of its $926M portfolio in Q1 2017.
  • Shufro Rose & Co opened 18 new positions and closed 10 in Q1 2017.
  • Shufro Rose & Co's portfolio value rose 3.4% quarter-over-quarter to $926M.

Based on Shufro Rose & Co's 13F filing for Q1 2017, filed 9 May 2017.